Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will release its first quarter 2026 financial results on , prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET. IPR&D and Milestones Organon does not currently expect to record any milestone expense in the first quarter ...
Organon To Report First Quarter 2026 Results and Host Conference Call ...
Organon is a global health care company dedicated to making a world of difference for women, their families and the communities they care for.
At Organon believe in a better and healthier every day for every woman. And we understand that women are foundational to a healthier world.
Organon is a global health company that provides ingenious solutions to improve women’s lives.
Organon’s products The product websites presented here are intended for use in the United States, its territories and Puerto Rico only. Other countries may have different regulatory requirements and review practices that may require referencing different information. If you are a resident of a country other than the United States, please see our worldwide locations to find information about ...
Organon, here for her health We are an independent global healthcare company dedicated to improving the health of women throughout their lives. Our diverse portfolio across women’s health and general medicines includes therapies and products for a wide range of conditions and diseases.
Organon, here for her health We are an independent global healthcare company with a strategy to improve the health of women throughout their lives. Our diverse portfolio across women's health, biosimilars, and established brands includes therapies and products for a wide range of conditions and diseases.